Literature DB >> 23623383

Endothelial TNF receptor 2 induces IRF1 transcription factor-dependent interferon-β autocrine signaling to promote monocyte recruitment.

Deepak Venkatesh1, Thomas Ernandez, Florencia Rosetti, Ibrahim Batal, Xavier Cullere, Francis W Luscinskas, Yuzhi Zhang, George Stavrakis, Guillermo García-Cardeña, Bruce H Horwitz, Tanya N Mayadas.   

Abstract

Endothelial-dependent mechanisms of mononuclear cell influx are not well understood. We showed that acute stimulation of murine microvascular endothelial cells expressing the tumor necrosis factor receptors TNFR1 and TNFR2 with the soluble cytokine TNF led to CXCR3 chemokine generation. The TNF receptors signaled through interferon regulatory factor-1 (IRF1) to induce interferon-β (IFN-β) and subsequent autocrine signaling via the type I IFN receptor and the transcription factor STAT1. Both TNFR2 and TNFR1 were required for IRF1-IFNβ signaling and, in human endothelial cells TNFR2 expression alone induced IFN-β signaling and monocyte recruitment. In vivo, TNFR1 was required for acute renal neutrophil and monocyte influx after systemic TNF treatment, whereas the TNFR2-IRF1-IFN-β autocrine loop was essential only for macrophage accumulation. In a chronic model of proliferative nephritis, IRF1 and renal-expressed TNFR2 were essential for sustained macrophage accumulation. Thus, our data identify a pathway in endothelial cells that selectively recruits monocytes during a TNF-induced inflammatory response.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23623383      PMCID: PMC3760474          DOI: 10.1016/j.immuni.2013.01.012

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  50 in total

1.  A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis.

Authors:  M Comabella; J D Lünemann; J Río; A Sánchez; C López; E Julià; M Fernández; L Nonell; M Camiña-Tato; F Deisenhammer; E Caballero; M T Tortola; M Prinz; X Montalban; R Martin
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

Review 2.  CXCR3, inflammation, and autoimmune diseases.

Authors:  Stéphanie Lacotte; Susana Brun; Sylviane Muller; Hélène Dumortier
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

3.  Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro.

Authors:  Joanna M Kuldo; Johanna Westra; Sigridur A Asgeirsdóttir; Robbert J Kok; Koen Oosterhuis; Marianne G Rots; Jan P Schouten; Pieter C Limburg; Grietje Molema
Journal:  Am J Physiol Cell Physiol       Date:  2005-06-22       Impact factor: 4.249

4.  Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection.

Authors:  U Hoffmann; T Bergler; M Rihm; C Pace; B Krüger; P Rümmele; B Stoelcker; B Banas; D N Männel; B K Krämer
Journal:  Am J Transplant       Date:  2008-03-02       Impact factor: 8.086

5.  TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes.

Authors:  Anna Yarilina; Kyung-Hyun Park-Min; Taras Antoniv; Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2008-03-16       Impact factor: 25.606

6.  CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses.

Authors:  Jing Zhou; Paul C Y Tang; Lingfeng Qin; Peter M Gayed; Wei Li; Eleni A Skokos; Themis R Kyriakides; Jordan S Pober; George Tellides
Journal:  J Exp Med       Date:  2010-08-23       Impact factor: 14.307

7.  Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.

Authors:  Anna-Marie Fairhurst; Chun Xie; Yuyang Fu; Andrew Wang; Christopher Boudreaux; Xin J Zhou; Ricardo Cibotti; Anthony Coyle; John E Connolly; Edward K Wakeland; Chandra Mohan
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

Review 8.  Immunoregulatory role of TNFalpha in inflammatory kidney diseases.

Authors:  Thomas Ernandez; Tanya N Mayadas
Journal:  Kidney Int       Date:  2009-05-13       Impact factor: 10.612

9.  Type I interferon drives tumor necrosis factor-induced lethal shock.

Authors:  Liesbeth Huys; Filip Van Hauwermeiren; Lien Dejager; Eline Dejonckheere; Stefan Lienenklaus; Siegfried Weiss; Georges Leclercq; Claude Libert
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

10.  Type I interferon: potential therapeutic target for psoriasis?

Authors:  Yihong Yao; Laura Richman; Chris Morehouse; Melissa de los Reyes; Brandon W Higgs; Anmarie Boutrin; Barbara White; Anthony Coyle; James Krueger; Peter A Kiener; Bahija Jallal
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

View more
  50 in total

1.  Fungal pattern receptors down-regulate the inflammatory response by a cross-inhibitory mechanism independent of interleukin-10 production.

Authors:  Mario Rodríguez; Saioa Márquez; Juan Vladimir de la Rosa; Sara Alonso; Antonio Castrillo; Mariano Sánchez Crespo; Nieves Fernández
Journal:  Immunology       Date:  2016-11-09       Impact factor: 7.397

2.  Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages.

Authors:  Scott McComb; Erin Cessford; Norah A Alturki; Julie Joseph; Bojan Shutinoski; Justyna B Startek; Ana M Gamero; Karen L Mossman; Subash Sad
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

Review 3.  Contributions of monocytes to nervous system disorders.

Authors:  Juan Mauricio Garré; Guang Yang
Journal:  J Mol Med (Berl)       Date:  2018-07-21       Impact factor: 4.599

4.  Opposing Roles of Tyrosine Kinase Receptors Mer and Axl Determine Clinical Outcomes in Experimental Immune-Mediated Nephritis.

Authors:  Yuxuan Zhen; Stephen O Priest; Wen-Hai Shao
Journal:  J Immunol       Date:  2016-08-15       Impact factor: 5.422

Review 5.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 6.  Type I interferon in rheumatic diseases.

Authors:  Theresa L Wampler Muskardin; Timothy B Niewold
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 7.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

Review 8.  Insights into the biology and therapeutic implications of TNF and regulatory T cells.

Authors:  Benoit L Salomon
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 20.543

Review 9.  The Changing Landscape of Renal Inflammation.

Authors:  Thomas Ernandez; Tanya Norton Mayadas
Journal:  Trends Mol Med       Date:  2016-01-07       Impact factor: 11.951

10.  Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis.

Authors:  Yubin Zhang; Vinh Thai; Amanda McCabe; Maura Jones; Katherine C MacNamara
Journal:  Infect Immun       Date:  2014-02-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.